EUVIMEDEUVIMED entdecken
CrossrefInfokarte

High Altitude Head and Neck Paragangliomas: A First Sub‐Himalayan Experience

Sudesh Kumar, Niraj Gupta, Priyanka Thakur, Nitin Gupta, Anita Bodh

OTO Open · 2024-01 · 8 (1)

DOI: 10.1002/oto2.112 ↗
AbstractBibliografische Angaben

Abstract

Abstract Objectives High‐altitude natives have a high incidence of parangangliomas (PGL) of the head and neck, especially the carotid body tumor. The aim of this study is to describe the clinical presentation, pattern, altitude of residence, distribution, management, and follow‐up of head and neck paragangliomas (HNPGL) in our sub‐Himalayan population. Study Design Retrospective cohort study. Setting Academic tertiary care hospital. Methods Hospital records of 20 patients of HNPGL diagnosed from December 2017 to December 2021 were retrieved for analysis. Results Twenty patients with 23 HNPGL, with a mean age of 41.74 years were managed in our institute. The female‐to‐male ratio was 2.3: 1 and the mean follow‐up was 29.95 months. Nine had carotid body (CBPGL), 7 had tympanic (TPGL), 2 had jugular (JPGL), and 2 had vagal paragangliomas (VPGL). Multiple PGL were seen in 4 patients (20%). Majority of cases (all CBPGL and 57.14% of TPGL) were residents of the high altitude, and the rest were from the low altitude. Fifteen patients (8 CBPGL, 7 TPGL) were operated. There were no major complications except in a patient with large carotid body tumor required anastomosis of carotid artery. Five patients received stereotactic radiotherapy, and 1 malignant PGL received chemoradiotherapy. Conclusion In this study, JPGL and VPGL are common at low altitudes, whereas carotid body and tympanic PGL were the most common tumor at high altitudes. Being a retrospective and study small sample size, a definite conclusion is not established, however, a genetic analysis and inclusion of a wider population in a future prospective study may establish the hypothesis.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →